Geodon: 20 mg (1 ea) Pharmacology Mechanism of Action
Azopt
Geodon (ziprasidone) is an oral medication approved to treat schizophrenia and bipolar disorder in adults
Geodon has an average rating of 5
If you have diabetes or have risk factors or symptoms of diabetes, your blood sugar should be monitored
There have been few reports of hyperglycemia or diabetes in patients treated with GEODON, and it is not known if GEODON is associated with these reactions
Chemically, ziprasidone hydrochloride monohydrate is 5-[2-[4-(1,2-benzisothiazol-3-yl)-1 piperazinyl]ethyl]-6-chloro-1,3-dihydro-2
It is also available as an oral suspension and as a solution for intramuscular injection
Dyslipidemia: Undesirable alterations have been observed in Borderline to High (≥150 mg/dL and <200 mg/dL to ≥200
Atypical antipsychotic drugs, including Geodon, have been linked to changes in overall body metabolism, including high blood sugar, poor cholesterol control, and weight gain
Increases in cholesterol and weight gain have also been reported with medicines like GEODON
Mania/psychosis: 40 to 80 mg PO BID; Acute agitation: 10-20mg IM q2-4h, 40mg max daily; Pediatric Dosing
Common causes of high blood sugar in people with high blood sugar--increased thirst, increased urination, dry mouth, fruity breath odor; or severe nervous system reaction --very stiff (rigid) muscles, high fever, sweating, confusion, agitation Geodon
While there is no body of evidence available to answer the question of how long a patient treated with ziprasidone should remain on it, a maintenance study in patients who had been symptomatically stable and then randomized to continue ziprasidone or switch to placebo demonstrated a delay in time to relapse for
Level 1 hypoglycemia is defined as a measurable glucose concentration less than 70 milligrams per deciliter (mg/dL) or 3
They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc